Technical Analysis for PETQ - PetIQ, Inc.

Grade Last Price % Change Price Change
grade F 26.43 4.80% 1.21
PETQ closed up 4.8 percent on Monday, October 14, 2019, on 62 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical PETQ trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
BB Squeeze Ended Range Expansion 4.80%
Below Lower BB Weakness 4.80%
Down 3 Days in a Row Weakness 4.80%
Down 4 Days in a Row Weakness 4.80%

Older signals for PETQ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Manufacturing Retail Stores Pain Diabetes Control Products Antibiotics Arthritis Wellness Products E Commerce Channels Zoonoses Dirofilaria Immitis Rimadyl Wellness
Is PETQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.33
52 Week Low 21.29
Average Volume 395,172
200-Day Moving Average 29.5812
50-Day Moving Average 29.1153
20-Day Moving Average 26.6123
10-Day Moving Average 26.535
Average True Range 1.2676
ADX 26.56
+DI 17.1275
-DI 24.0185
Chandelier Exit (Long, 3 ATRs ) 24.0322
Chandelier Exit (Short, 3 ATRs ) 28.9828
Upper Bollinger Band 27.9552
Lower Bollinger Band 25.2694
Percent B (%b) 0.43
BandWidth 10.092326
MACD Line -0.7685
MACD Signal Line -0.8496
MACD Histogram 0.0811
Fundamentals Value
Market Cap 349.48 Million
Num Shares 13.2 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 52.86
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.88
Resistance 3 (R3) 28.74 27.80 28.47
Resistance 2 (R2) 27.80 27.17 27.86 28.33
Resistance 1 (R1) 27.11 26.79 27.46 27.25 28.20
Pivot Point 26.17 26.17 26.34 26.23 26.17
Support 1 (S1) 25.48 25.54 25.83 25.62 24.66
Support 2 (S2) 24.54 25.16 24.60 24.53
Support 3 (S3) 23.85 24.54 24.39
Support 4 (S4) 23.99